News about Industrial talks

KAISHA Group's initial reaction to the Indian Union Budget 2021-22 for pharma; announces further increase in vial production capacity by 2022

KAISHA Group's initial reaction to the Indian Union Budget 2021-22 for pharma; announces further increase in vial production capacity by 2022

After the announcement by Indian Finance Minister, Nirmala Sitharaman to commit a 137% budget increase for healthcare and a nearly 200% boost for developing the pharma sector instills a high level of optimism in the industry.

Industrial talks | 04/02/2021 | By Hemant

Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19

Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19

Roche and Regeneron announced today that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regeneron?s investigational antiviral antibody combination, to people around the globe.

Industrial talks | 21/08/2020 | By Darshana 285

Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad

Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad

With Hyderabad fast emerging as Indias hub for medical devices manufacturing, the US-based Medtronic has decided to further consolidate its base in India in the medical devices manufacturing sector. As part of this, the company has decided to invest Rs. 1,200 crore to scale up and expand its current R&D centre into a state-of-the-art engineering

Industrial talks | 17/08/2020 | By Darshana 128

Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities

Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities

The Amazon Pharmacy service has currently opened in Bengaluru. The company plans its foray into other metros thereafter. Customers can now order via its platform: amazon.in all medicines via prescription. In addition nutraceuticals supplements, Ayurveda medicines and medical devices can also be ordered

Industrial talks | 14/08/2020 | By Darshana 105

Sanofi receives Health Canada approval for Sarclisa in combo with pomalidomide & dexamethasone to treat r/r multiple myeloma

Sanofi receives Health Canada approval for Sarclisa in combo with pomalidomide & dexamethasone to treat r/r multiple myeloma

Sanofi Canada announced that Health Canada has approved Sarclisa in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor

Industrial talks | 10/07/2020 | By Darshana 207

India announces collaboration with Australia for Covid-19

India announces collaboration with Australia for Covid-19

Prime Minister Narendra Modi and the Prime Minister of Australia, Scott Morrison MP, announced a COVID-19 collaboration in 2020 during an India-Australia leaders? virtual summit held on June 4, 2020

Industrial talks | 08/06/2020 | By Darshana 236

NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask

NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask

To ensure the availability of N-95 masks at the revised MRPs as per price control compliance, the National Pharmaceutical Pricing Authority (NPPA) has issued a list of price reduction in N-95 masks by four major N-95 mask manufacturers, namely Venus Safety and Health Pvt Ltd, Magnum Health and Safety, Yash Care Life Sciences and Joseph Leslie & Co

Industrial talks | 08/06/2020 | By Darshana 177

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharma to study potential Covid-19 drug combination

Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment

Industrial talks | 26/05/2020 | By Darshana 214

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancer

Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children

Industrial talks | 25/05/2020 | By Darshana 181

Lupin?s Pithampur Unit-1 facility receives EIR from U.S. FDA

Lupin?s Pithampur Unit-1 facility receives EIR from U.S. FDA

Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020

Industrial talks | 30/04/2020 | By Darshana 120

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology